Imunon, Inc. - Common Stock — Cash Flow (NASDAQ:IMNN)

Financials

Cash from operating activities -15.62 M-16.22 M-23.13 M-19.02 M-18.85 M-13.9 M -15.03 M Cash from investing activities 7.92 M-30.12 M8.32 M11.01 M9.83 M-280.57 K -20.92 K Cash from financing activities 17.98 M54.77 M6.72 M-3.64 M9.06 M17.09 M 16.98 M Free cash flow -15.62 M-16.22 M-23.13 M-19.02 M-18.85 M-14.18 M -15.06 M

News

Imunon, Inc. (IMNN) Q1 2026 Earnings Call Transcript

Imunon stock price target raised to $25 from $14 at H.C. Wainwright

Imunon stock rises following strategic restructuring to focus on Phase 3 trial

Brookline Capital lowers Imunon stock price target to $16 on offering dilution

IMUNON raises $7 million in registered direct offering

Earnings call transcript: Imunon Q3 2025 sees stock volatility post-call

Imunon, Inc. (IMNN) Discusses IMNN-001 Immunotherapy Progress and Milestones in OVATION 3 Ovarian Cancer Study Transcript

IMUNON provides updates on ovarian cancer immunotherapy program

IMUNON to present new data on ovarian cancer therapy at SITC meeting

IMUNON begins Phase 3 trial of ovarian cancer immunotherapy

IMUNON reports positive data from ovarian cancer immunotherapy study

IMUNON to present new data on ovarian cancer therapy at AACR conference